Mast Cells and Angiogenesis in Pancreatic Ductal Adenocarcinoma

Overview

Journal Clin Exp Med

Specialty General Medicine

Date 2018 Mar 2

PMID 29492715

Citations 24

Authors

Vito Longo

Roberto Tamma

Oronzo Brunetti

Salvatore Pisconti

Antonella Argentiero

Nicola Silvestris

Domenico Ribatti

Affiliations

Soon will be listed here.

Abstract

Mast cells are recognized as critical components of the tumor stromal microenvironment in several solid and hematological malignancies, promoting angiogenesis and tumor growth. A correlation between mast cells infiltration, angiogenesis and tumor progression has been reported for pancreatic ductal adenocarcinoma as well. Mast cells contribute to the aggressiveness of the pancreatic ductal carcinoma enhancing the expression of several pro-angiogenic factors such as vascular endothelial growth factor, fibroblast growth factor-2, platelet-derived growth factor and angiopoietin-1 as well as stimulating the pancreatic cancer cells proliferation by IL-13 and tryptase. The disruption of this pro-angiogenic and proliferative stimulation by inhibiting the mast cells migration and degranulation is under investigation as a potential therapeutic approach in pancreatic ductal adenocarcinoma patients. This review will summarize the literature concerning the mast cells infiltration in the pancreatic ductal adenocarcinoma analyzing its role in angiogenesis and tumor progression.

Citing Articles

Immunomodulatory Significance of Mast Cell Exosomes (MC-EXOs) in Immune Response Coordination.

Elieh-Ali-Komi D, Shafaghat F, Alipoor S, Kazemi T, Atiakshin D, Pyatilova P Clin Rev Allergy Immunol. 2025; 68(1):20.

PMID: 39976807 PMC: 11842441. DOI: 10.1007/s12016-025-09033-6.

gene expression as a prognostic marker for clinical outcomes in lung adenocarcinoma.

Qiu L, Li T, Qing B, Zhao C, Zhang X, Watanabe S Transl Lung Cancer Res. 2025; 14(1):224-238.

PMID: 39958209 PMC: 11826265. DOI: 10.21037/tlcr-24-623.

Mast cells: key players in digestive system tumors and their interactions with immune cells.

Shu F, Yu J, Liu Y, Wang F, Gou G, Wen M Cell Death Discov. 2025; 11(1):8.

PMID: 39814702 PMC: 11735678. DOI: 10.1038/s41420-024-02258-y.

Renal Mast Cell-Specific Proteases in the Pathogenesis of Tubulointerstitial Fibrosis.

Atiakshin D, Morozov S, Dlin V, Kostin A, Volodkin A, Ignatyuk M J Histochem Cytochem. 2024; 72(8-9):495-515.

PMID: 39263893 PMC: 11529666. DOI: 10.1369/00221554241274878.

New insights into the role of mast cells as a therapeutic target in cancer through the blockade of immune checkpoint inhibitors.

Ribatti D Front Med (Lausanne). 2024; 11:1373230.

PMID: 38482531 PMC: 10933100. DOI: 10.3389/fmed.2024.1373230.

References

da Silva E, Jamur M, Oliver C . Mast cell function: a new vision of an old cell. J Histochem Cytochem. 2014; 62(10):698-738. PMC: 4230976. DOI: 10.1369/0022155414545334. View

Vukman K, Forsonits A, Oszvald A, Toth E, Buzas E . Mast cell secretome: Soluble and vesicular components. Semin Cell Dev Biol. 2017; 67:65-73. DOI: 10.1016/j.semcdb.2017.02.002. View

Guo X, Zhai L, Xue R, Shi J, Zeng Q, Gao C . Mast Cell Tryptase Contributes to Pancreatic Cancer Growth through Promoting Angiogenesis via Activation of Angiopoietin-1. Int J Mol Sci. 2016; 17(6). PMC: 4926368. DOI: 10.3390/ijms17060834. View

Provenzano P, Cuevas C, Chang A, Goel V, Von Hoff D, Hingorani S . Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012; 21(3):418-29. PMC: 3371414. DOI: 10.1016/j.ccr.2012.01.007. View

Huang B, Lei Z, Zhang G, Li D, Song C, Li B . SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood. 2008; 112(4):1269-79. PMC: 2515142. DOI: 10.1182/blood-2008-03-147033. View

Varricchi G, Galdiero M, Loffredo S, Marone G, Iannone R, Marone G . Are Mast Cells MASTers in Cancer?. Front Immunol. 2017; 8:424. PMC: 5388770. DOI: 10.3389/fimmu.2017.00424. View

Cimpean A, Tamma R, Ruggieri S, Nico B, Toma A, Ribatti D . Mast cells in breast cancer angiogenesis. Crit Rev Oncol Hematol. 2017; 115:23-26. DOI: 10.1016/j.critrevonc.2017.04.009. View

Ammendola M, Sacco R, Sammarco G, Donato G, Zuccala V, Luposella M . Mast cells density positive to tryptase correlates with angiogenesis in pancreatic ductal adenocarcinoma patients having undergone surgery. Gastroenterol Res Pract. 2014; 2014:951957. PMC: 4065688. DOI: 10.1155/2014/951957. View

Strouch M, Cheon E, Salabat M, Krantz S, Gounaris E, Melstrom L . Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin Cancer Res. 2010; 16(8):2257-65. PMC: 3122919. DOI: 10.1158/1078-0432.CCR-09-1230. View

10.

Lasser C, Shelke G, Yeri A, Kim D, Crescitelli R, Raimondo S . Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing. RNA Biol. 2016; 14(1):58-72. PMC: 5270547. DOI: 10.1080/15476286.2016.1249092. View

11.

Kinet J . The essential role of mast cells in orchestrating inflammation. Immunol Rev. 2007; 217:5-7. DOI: 10.1111/j.1600-065X.2007.00528.x. View

12.

Jacobetz M, Chan D, Neesse A, Bapiro T, Cook N, Frese K . Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut. 2012; 62(1):112-20. PMC: 3551211. DOI: 10.1136/gutjnl-2012-302529. View

13.

Buchler P, Reber H, Buchler M, Shrinkante S, Buchler M, Friess H . Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas. 2002; 26(1):56-64. DOI: 10.1097/00006676-200301000-00010. View

14.

Shibaji T, Nagao M, Ikeda N, Kanehiro H, Hisanaga M, Ko S . Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer. Anticancer Res. 2004; 23(6C):4721-7. View

15.

Ammendola M, Leporini C, Marech I, Gadaleta C, Scognamillo G, Sacco R . Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy. Biomed Res Int. 2014; 2014:154702. PMC: 4177740. DOI: 10.1155/2014/154702. View

16.

Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F . Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol. 2004; 57(6):630-6. PMC: 1770337. DOI: 10.1136/jcp.2003.014498. View

17.

Chang D, Ma Y, Ji B, Wang H, Deng D, Liu Y . Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2011; 17(22):7015-23. PMC: 4089502. DOI: 10.1158/1078-0432.CCR-11-0607. View

18.

Karamitopoulou E, Shoni M, Theoharides T . Increased number of non-degranulated mast cells in pancreatic ductal adenocarcinoma but not in acute pancreatitis. Int J Immunopathol Pharmacol. 2014; 27(2):213-20. DOI: 10.1177/039463201402700208. View

19.

Wang Z, Ding Y, Miki T, Warita K, Matsumoto Y, Takeuchi Y . Nerve growth factor and receptors are significantly affected by histamine stimulus through H1 receptor in pancreatic carcinoma cells. Mol Med Rep. 2011; 3(1):103-9. DOI: 10.3892/mmr_00000225. View

20.

Francis T, Graf A, Hodges K, Kennedy L, Hargrove L, Price M . Histamine regulation of pancreatitis and pancreatic cancer: a review of recent findings. Hepatobiliary Surg Nutr. 2014; 2(4):216-26. PMC: 3924685. DOI: 10.3978/j.issn.2304-3881.2013.08.06. View